NCT04018157View on ClinicalTrials.gov

Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 3, 2019

Primary Completion Date

November 20, 2019

Study Completion Date

November 23, 2019

Conditions
Agitation, Emergence
Interventions
DRUG

"Ketamine and dexmedetomidine and propofol and 0.9%saline"

patients will receive single intravenous bolus of combination from ketamine 0.5mg/kg and dexmedetomidine 1ug/kg in one syringe diluted in 10 ml 0.9% saline.

Trial Locations (1)

022/055

Faculty of Medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04018157 - Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries | Biotech Hunter | Biotech Hunter